TABLE OF CONTENTS
1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 OVERVIEW OF LATIN AMERICA HEMODYNAMIC MONITORING SYSTEM MARKET 19
1.4 CURRENCY AND PRICING 20
1.5 LIMITATIONS 20
1.6 MARKETS COVERED 20
1.6.1 LATIN AMERICA 21
2 MARKET SEGMENTATION 23
2.1 MARKETS COVERED 23
2.2 LATIN AMERICA HEMODYNAMIC MONITORING SYSTEM MARKET: GEOGRAPHICAL SCOPE 24
2.3 YEARS CONSIDERED FOR THE STUDY 24
2.4 CURRENCY AND PRICING 24
2.5 DBMR TRIPOD DATA VALIDATION MODEL 25
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
2.7 DBMR MARKET POSITION GRID 29
2.8 DBMR VENDOR SHARE ANALYSIS 31
2.9 MULTIVARIATE MODELING 31
2.10 PRODUCTS LIFELINE CURVE 32
2.11 SECONDARY SOURCES 33
2.12 ASSUMPTIONS 33
3 MARKET OVERVIEW 34
3.1 DRIVERS 36
3.1.1 RISING CASES OF CARDIOVASCULAR DISEASES AND DIABETES 36
3.1.2 CONTINUOUS TECHNOLOGICAL ADVANCEMENTS IN HEMODYNAMIC MONITORING SYSTEMS 36
3.1.3 RISING GERIATRIC POPULATION AND GROWING NUMBER OF SURGERIES 37
3.1.4 RISING GOVERNMENT FOCUSES TOWARDS CRITICAL CARE INFRASTRUCTURE AND SERVICES 38
3.2 RESTRAINTS: 39
3.2.1 PRODUCT RECALLS 39
3.2.2 RISKS ASSOCIATED WITH INVASIVE HEMODYNAMIC MONITORING 39
3.3 OPPORTUNITIES 40
3.3.1 PREFERENCE TOWARDS THE LESS INVASIVE TREATMENTS 40
3.3.2 GROWING DEMAND FOR PATIENT MONITORING DEVICES IN NON-HOSPITAL SETTINGS 41
?
3.4 CHALLENGE 42
3.4.1 LACK OF SKILLED PROFESSIONALS 42
4 EXECUTIVE SUMMARY 43
5 PREMIUM INSIGHTS 45
6 LATIN AMERICA HEMODYNAMIC MONITORING SYSTEM MARKET, BY TYPE 46
6.1 OVERVIEW 47
6.2 NON-INVASIVE HEMODYNAMIC MONITORING SYSTEMS 48
6.3 MINIMALLY-INVASIVE HEMODYNAMIC MONITORING SYSTEMS 49
6.4 INVASIVE HEMODYNAMIC MONITORING SYSTEMS 50
7 LATIN AMERICA HEMODYNAMIC MONITORING SYSTEM MARKET, BY PRODUCTS 51
7.1 OVERVIEW 52
7.2 VISUALIZATION MONITORS 53
7.2.1 BLOOD PRESSURE MONITORS 54
7.2.2 BLOOD GLUCOSE MONITORS 54
7.3 CATHETER 54
7.3.1 PULMONARY ARTERY CATHETER 55
7.3.2 CENTRAL VENOUS CATHETER 55
7.3.3 ARTERIAL CATHETER 55
7.4 ANALYZERS 55
7.4.1 PULSE CONTOUR ANALYZERS 56
7.4.2 BLOOD GAS & ELECTROLYTE ANALYZERS 56
7.4.3 CHOLESTEROL ANALYZERS 56
7.5 PRESSURE MONITORING DEVICES 56
7.6 MONITORING SENSORS 57
7.7 RECORDING SYSTEM 57
7.8 SOFTWARE 57
7.9 ACCESSORIES 58
7.9.1 PROBES 58
7.9.2 CABLES 58
7.9.3 FLUSH DEVICES 59
7.9.4 TUBING 59
7.9.5 HOLDERS AND MOUNTS 59
7.9.6 OTHERS 59
7.10 OTHERS 59
?
8 LATIN AMERICA HEMODYNAMIC MONITORING SYSTEM MARKET, BY END USER 60
8.1 OVERVIEW 61
8.2 HOSPITALS AND CLINICS 62
8.3 AMBULATORY SURGICAL CENTERS 62
8.4 CATHETERIZATION LABS 63
8.5 RESEARCH INSTITUTIONS & ACADEMY 63
8.6 HOME CARE SETTINGS 63
9 LATIN AMERICA HEMODYNAMIC MONITORING SYSTEM MARKET,
BY DISTRIBUTION CHANNEL 64
9.1 OVERVIEW 65
9.2 DIRECT TENDER 66
9.3 RETAILER 66
10 LATIN AMERICA HEMODYNAMIC MONITORING SYSTEM MARKET BY COUNTRY 67
10.1.1 BRAZIL 71
10.1.2 MEXICO 74
10.1.3 ARGENTINA 77
10.1.4 CHILE 80
10.1.5 URUGUAY 83
10.1.6 PERU 86
10.1.7 COLOMBIA 89
10.1.8 PARAGUAY 92
10.1.9 ECUADOR 95
10.1.10 COSTA RICA 98
10.1.11 PANAMA 101
10.1.12 BOLIVIA 104
10.1.13 PUERTO RICO 107
10.1.14 DOMINICAN REPUBLIC 110
10.1.15 VENEZUELA 113
10.1.16 REST OF LATIN AMERICA 116
11 LATIN AMERICA HEMODYNAMIC MONITORING SYSTEM MARKET, COMPANY LANDSCAPE 117
11.1 COMPANY SHARE ANALYSIS: SOUTH AMERICA 117
12 SWOT ANALYSIS 118
?
13 COMPANY PROFILE 124
13.1 EDWARDS LIFESCIENCES CORPORATION 124
13.1.1 COMPANY SNAPSHOT 124
13.1.2 REVENUE ANALYSIS 124
13.1.3 GEOGRAPHICAL PRESENCE 125
13.1.4 PRODUCT PORTFOLIO 125
13.1.5 RECENT DEVELOPMENTS 127
13.2 GETINGE AB 128
13.2.1 COMPANY SNAPSHOT 128
13.2.2 REVENUE ANALYSIS 128
13.2.3 GEOGRAPHICAL PRESENCE 129
13.2.4 PRODUCT PORTFOLIO 129
13.2.5 RECENT DEVELOPMENT 130
13.3 ICU MEDICAL, INC. 131
13.3.1 COMPANY SNAPSHOT 131
13.3.2 REVENUE ANALYSIS 131
13.3.3 GEOGRAPHICAL PRESENCE 132
13.3.4 PRODUCT PORTFOLIO 132
13.3.5 RECENT DEVELOPMENTS 134
13.4 CHEETAH MEDICAL 135
13.4.1 COMPANY SNAPSHOT 135
13.4.2 GEOGRAPHICAL PRESENCE 135
13.4.3 PRODUCT PORTFOLIO 136
13.4.4 RECENT DEVELOPMENT 136
13.5 DRaGERWERK AG & CO. KGAA. 137
13.5.1 COMPANY SNAPSHOT 137
13.5.2 REVENUE ANALYSIS 137
13.5.3 GEOGRAPHICAL PRESENCE 138
13.5.4 PRODUCT PORTFOLIO 138
13.5.5 RECENT DEVELOPMENT 139
13.6 LIDCO 140
13.6.1 COMPANY SNAPSHOT 140
13.6.2 REVENUE ANALYSIS 140
13.6.3 GEOGRAPHICAL PRESENCE 141
13.6.4 PRODUCT PORTFOLIO 141
13.6.5 RECENT DEVELOPMENTS 142
13.7 CNSYSTEMS MEDIZINTECHNIK GMBH. 143
13.7.1 COMPANY SNAPSHOT 143
13.7.2 GEOGRAPHICAL PRESENCE 143
13.7.3 PRODUCT PORTFOLIO 144
13.7.4 RECENT DEVELOPMENT 145
13.8 DELTEX MEDICAL 146
13.8.1 COMPANY SNAPSHOT 146
13.8.2 REVENUE ANALYSIS 146
13.8.3 GEOGRAPHICAL PRESENCE 147
13.8.4 PRODUCT PORTFOLIO 147
13.8.5 RECENT DEVELOPMENTS 148
13.9 FUJIFILM CORPORATION 149
13.9.1 COMPANY SNAPSHOT 149
13.9.2 REVENUE ANALYSIS 149
13.9.3 GEOGRAPHICAL PRESENCE 150
13.9.4 PRODUCT PORTFOLIO 150
13.9.5 RECENT DEVELOPMENT 150
13.10 GENERAL ELECTRIC 151
13.10.1 COMPANY SNAPSHOT 151
13.10.2 REVENUE ANALYSIS 151
13.10.3 GEOGRAPHICAL PRESENCE 152
13.10.4 PRODUCT PORTFOLIO 152
13.10.5 RECENT DEVELOPMENT 152
13.11 KONINKLIJKE PHILIPS N.V. 153
13.11.1 COMPANY SNAPSHOT 153
13.11.2 REVENUE ANALYSIS 153
13.11.3 GEOGRAPHICAL PRESENCE 154
13.11.4 PRODUCT PORTFOLIO 154
13.11.5 RECENT DEVELOPMENTS 155
13.12 NI MEDICAL 156
13.12.1 COMPANY SNAPSHOT 156
13.12.2 GEOGRAPHICAL PRESENCE 156
13.12.3 PRODUCT PORTFOLIO 157
13.12.4 RECENT DEVELOPMENT 157
13.13 OSYPKA MEDICAL GMBH 158
13.13.1 COMPANY SNAPSHOT 158
13.13.2 GEOGRAPHICAL PRESENCE 158
13.13.3 PRODUCT PORTFOLIO 159
13.13.4 RECENT DEVELOPMENTS 159
?
13.14 USCOM 160
13.14.1 COMPANY SNAPSHOT 160
13.14.2 REVENUE ANALYSIS 160
13.14.3 GEOGRAPHICAL PRESENCE 161
13.14.4 PRODUCT PORTFOLIO 161
13.14.5 RECENT DEVELOPMENTS 161
14 QUESTIONNAIRE 162
15 CONCLUSION 165
16 RELATED REPORTS 166
?